Claim · 2021-09-14 · publication · Stated in source · Supported

Mullard's Nature Reviews Drug Discovery news article "What does AlphaFold mean for drug discovery?" (14 September 2021) says in its standfirst that the implications of AlphaFold and RoseTTAFold for drug discovery are more incremental than their advance in structure prediction.

One recorded claim. The claim panel gives its qualification, the source passages with their place in each source, and how it was checked.

What it connects

What does AlphaFold mean for drug discovery? → bears on → Predicted protein structures aid drug design

Where it appears

AI in science →

Claim and evidence

What does AlphaFold mean for drug discovery?bears on ↓Predicted protein structures aid drug design

Machine-checked, not reviewed by an editorStated in sourceSupported

Supporting evidence: secondary · 1 source

Date: 2021-09-14 · publication Records dated 2021 →
Role: Context
Register (kind of text): Nonfiction
Missing element: Assesses the degree of the implications for drug discovery ("more incremental"); it does not state that predicted structures are of no use, nor that they are of use.

Scope and limitsThe record documents what this text states, in its register; it is not evidence that the proposition is true and implies no influence on or from any other text. Journalism (secondary source). Only the standfirst and the opening paragraph were readable; the body, which may give the reasoning and named sources, was not read.

Rests on reportingNo primary source supports this record; its supporting passages come from reporting.

The evidence 01

secondary sourceSupports the claim

What does AlphaFold mean for drug discovery?

Nature Reviews Drug Discovery · 2021-09-14

Cite the original source

Cite the original document, not Selekoa. Check these details against it.

Source excerpt

“but the implications for drug discovery are more incremental. For now.”

Location in source Standfirst

How it was read Retrieved directly from the publisher

Machine-checked · 2026-10-30

Source details and check notes

Authors: Asher Mullard
Version: Retrieved for the candidate pack on 2026-10-30 (SHA-256 9e7115bb6c20032a92f104778da4e24a63f965e1731d2fe03d6428ce42acb2e9). Nature Reviews Drug Discovery news article page as served on 2026-10-30; standfirst and opening paragraph only, remainder behind subscription. Its wording can change; earlier wording is not authenticated.
Canonical address: Open the canonical source ↗
Accessed: 2026-10-30
Language: English (en)
Attribution: Asher Mullard, “What does AlphaFold mean for drug discovery?”, 2021-09-14.
Reuse: No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution.
Check notes: Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (11 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. The standfirst is the publication's own summary. A cross-family machine check (2026-10-30, item B107) re-read the record’s sources and found full support. No human editorial review.

Status and meaning

Editorial status. Not reviewed by an editor. An exploratory record that no editor has accepted. This status does not say whether a person has read any linked passage. Each evidence record above shows how it was checked.

Relation. A passage of the document bears on the proposition without meeting its criterion; the record names the missing element. It is not an articulation and implies no influence.

Date. Date printed on the article page.

Record ID aib-arg-p1-mullard-2021